...
首页> 外文期刊>Biochemical and Biophysical Research Communications >Positive regulation of the Egr-1/osteopontin positive feedback loop in rat vascular smooth muscle cells by TGF-beta, ERK, JNK, and p38 MAPK signaling.
【24h】

Positive regulation of the Egr-1/osteopontin positive feedback loop in rat vascular smooth muscle cells by TGF-beta, ERK, JNK, and p38 MAPK signaling.

机译:通过TGF-β,ERK,JNK和p38 MAPK信号传导对大鼠血管平滑肌细胞中Egr-1 /骨桥蛋白正反馈环的正向调节。

获取原文
获取原文并翻译 | 示例
           

摘要

Previous studies identified a positive feedback loop in rat vascular smooth muscle cells (VSMCs) in which early growth response factor-1 (Egr-1) binds to the osteopontin (OPN) promoter and upregulates OPN expression, and OPN upregulates Egr-1 expression via the extracellular signal-regulated protein kinase (ERK) signaling pathway. The current study examined whether transforming growth factor-beta (TGF-beta) activity contributes to Egr-1 binding to the OPN promoter, and whether other signaling pathways act downstream of OPN to regulate Egr-1 expression. ChIP assays using an anti-Egr-1 antibody showed that amplification of the OPN promoter sequence decreased in TGF-beta DNA enzyme-transfected VSMCs relative to control VSMCs. Treatment of VSMCs with PD98059 (ERK inhibitor), SP600125 (JNK inhibitor), or SB203580 (p38 MAPK inhibitor) significantly inhibited OPN-induced Egr-1 expression, and PD98059 treatment was associated with the most significant decrease in Egr-1 expression. OPN-stimulated VSMC cell migration was inhibited by SP600125 or SB203580, but not by PD98059. Furthermore, MTT assays showed that OPN-mediated cell proliferation was inhibited by PD98059, but not by SP600125 or SB203580. Taken together, the results of the current study show that Egr-1 binding to the OPN promoter is positively regulated by TGF-beta, and that the p38 MAPK, JNK, and ERK pathways are involved in OPN-mediated Egr-1 upregulation.
机译:先前的研究在大鼠血管平滑肌细胞(VSMC)中发现了一个正反馈回路,其中早期生长反应因子1(Egr-1)与骨桥蛋白(OPN)启动子结合并上调OPN表​​达,而OPN通过以下途径上调Egr-1表达细胞外信号调节蛋白激酶(ERK)信号通路。当前的研究检查了转化生长因子-β(TGF-β)的活性是否有助于Egr-1与OPN启动子的结合,以及其他信号通路是否在OPN的下游调节Egr-1的表达。使用抗Egr-1抗体的ChIP分析表明,相对于对照VSMC,TGF-βDNA酶转染的VSMC中OPN启动子序列的扩增降低。用PD98059(ERK抑制剂),SP600125(JNK抑制剂)或SB203580(p38 MAPK抑制剂)治疗VSMC可显着抑制OPN诱导的Egr-1表达,PD98059治疗与Egr-1表达的最显着降低有关。 OPN刺激的VSMC细胞迁移受SP600125或SB203580抑制,但不受PD98059抑制。此外,MTT分析显示OPN介导的细胞增殖受PD98059抑制,但不受SP600125或SB203580抑制。综上所述,当前研究的结果表明,Egr-1与OPN启动子的结合受到TGF-β的正调控,而p38 MAPK,JNK和ERK通路参与了OPN介导的Egr-1的上调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号